The startup develops a non-invasive blood test that utilizes biomarker analysis for the early detection of lung cancer. This technology enables patients to identify lung cancer at a treatable stage, significantly improving survival rates.

AIDO develops an intelligent, modular assistant system compatible with existing endoscopes to enhance practitioner performance during complex endoscopic procedures. This technology facilitates non-invasive treatment and standardized biopsy collection for digestive and pancreatic cancers. The system aims to improve early diagnosis and patient outcomes while optimizing resource utilization in endoscopy.

Allergios develops an in-vitro allergy diagnostic system that directly visualizes the allergic response using patient blood serum. This method analyzes allergen-specific degranulation of basophil cells via a disposable microfluidic chip and optical reader. The platform aims to provide safe, unambiguous allergy diagnoses, initially focusing on replacing cumbersome food challenge testing.

Altach Biomedical develops biomimetic cartilage grafts utilizing Type II collagen to create scaffolds that facilitate the regeneration of cartilage defects. This technology addresses the high incidence of untreated cartilage defects, which can lead to osteoarthritis and often result in unsatisfactory long-term outcomes with current repair solutions.

This startup develops a patient-specific surgical system for orthopedic revision surgery, focusing on precise bone cement removal. Their platform uses digital joint mapping and surgical planning to create intelligent surgical guides and a precision-guided removal device, aiming to improve patient outcomes and reduce surgical time.

Angiogenesis Analytics provides PCaVision, an AI-powered software that analyzes multi-modal 3D ultrasound data to identify suspicious regions in prostate cancer diagnosis. This solution streamlines the diagnostic workflow, enabling urologists to perform targeted biopsies with greater accuracy and efficiency.

Ansana provides smart sterilization technology for healthcare, focusing on surgical instrument reprocessing management. Their system uses integrated sensors and real-time tracking to ensure instrument sterility, improve operating room efficiency, and reduce process consumables. This technology supports quality release, inventory optimization, and streamlined reprocessing workflows for hospitals.

The startup develops a real-time monitoring algorithm for neonatal patients that tracks vital parameters such as heart rate, oxygen saturation, respiration, and temperature. This technology enables neonatologists and pediatricians to make informed clinical decisions for managing neonatal complications effectively.

This startup provides a remote patient monitoring system that uses a chest-worn sensor patch and health questionnaires to collect physiological data. The system analyzes this data to assess patient fitness for surgery and predict surgical complications, presenting real-time insights on a clinical dashboard for surgical teams.

This medical device company develops an intramedullary fracture fixation system for complex long bone fractures. Their system features rotational implant components that provide precise control, enabling improved patient outcomes for conditions like bone degeneration and gait abnormalities.

The startup develops wearable phototherapy devices that utilize targeted light distribution to treat jaundice in newborns while allowing for skin-to-skin contact and breastfeeding. This technology minimizes the need for traditional NICU phototherapy, enabling parents to manage their baby's condition more comfortably and effectively at home.

This startup develops a wearable capnograph for continuous, non-invasive patient monitoring. Its device addresses common issues like sample line clogging and offers portability and wireless capabilities, enabling reliable ventilation and perfusion monitoring in diverse healthcare settings, including homecare.

This company develops an automated respiratory rate measurement device for rapid and accurate pneumonia diagnosis in children under five. The technology provides healthcare workers in low-resource settings with objective, color-coded feedback, improving early detection rates. This scalable solution aims to reduce child mortality associated with delayed or inaccurate pneumonia classification.

The startup has developed a non-invasive intracranial pressure (ICP) measurement device that utilizes low-power infrared light technology and machine learning algorithms to provide continuous ICP estimates for traumatic brain injury (TBI) diagnosis. This technology enables clinicians to obtain critical ICP data without invasive procedures, improving patient care and treatment outcomes for TBI.

Ecomedic provides an AI-driven platform for hospitals and medical suppliers to conduct rapid, scientific assessments of Scope 3 emissions within their supply chains. The system utilizes proprietary data and machine learning to deliver verifiable Life Cycle Assessments (LCA) significantly faster and at a lower cost than traditional methods. This enables healthcare organizations to implement financially viable, circular solutions that reduce environmental impact across clinical pathways.

Eon transforms cloud backups into instantly accessible, strategic assets through a new storage tier designed for efficiency and control. The platform provides automated backup posture management, global search capabilities, and granular restoration for compliance and faster recovery. This cloud-native solution eliminates hidden costs and offers ransomware protection across multi-cloud environments.

Exolvo Biosciences develops oral delivery capsules that enable large‑molecule biologics to be administered without injections. The smart capsule incorporates dissolvable microneedles and modular sizing to maintain efficacy and manufacturability for diverse complex drugs. The technology aims to improve patient adherence, reduce administration costs, and expand access to biologic therapies.

Flash Pathology provides advanced, label-free imaging technology for real-time visualization of unprocessed tissue samples. This system eliminates the multi-step H&E staining process, enabling instant histology analysis directly from fresh tissue. The technology accelerates diagnostic workflows and supports immediate surgical margin assessment and biopsy analysis.

This health technology company develops a medical device that optimizes egg quality during IVF by maintaining consistent physiological temperatures during oocyte retrieval and selection. This device aims to improve embryology outcomes and enhance workflow efficiency in IVF labs, increasing the chances of successful conception for individuals undergoing IVF procedures.

Garland Surgical designs the MaltaHip, a total hip prosthesis that utilizes clinically proven materials and a patented assembly method to enhance lifespan and functionality. This device addresses the issue of frequent hip replacement surgeries by providing a durable solution that significantly reduces wear and the risk of dislocation, allowing for a wider range of motion.

The startup develops a medical device that utilizes a flushing therapy to minimize blood loss during open-heart surgery. This technology reduces the incidence of blood-related complications and the necessity for re-operations, enhancing patient recovery and lowering hospital costs.

HEMEO develops AI-based clinical decision support applications for coagulation management. This technology consolidates multi-source patient data into actionable insights for clinicians managing bleeding and thrombosis risks. The platform aims to personalize prevention and treatment protocols, potentially reducing morbidity, mortality, and the need for blood transfusions.

This startup develops a bacteria treatment technology and antimicrobials to prevent infections on medical devices. Their technology targets and kills antibiotic-resistant bacteria, and has also shown virucidal activity against coronaviruses on non-porous surfaces, helping to reduce healthcare-associated infections.

Implant Preservation Devices develops a non-contact induction heating technology to treat prosthetic joint and metal implant infections by effectively removing biofilm and bacterial colonization. This approach addresses the significant morbidity and economic burden associated with over 600,000 annual cases of implant infections.